免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

The Fourth Left Atrial Appendage Occlusion Study

NCT:NCT05963698 · RECRUITING

NCT IDNCT05963698
狀態RECRUITING
開始日期2023-11-30
完成時間2029-12-01
SponsorHamilton Health Sciences Corporation (OTHER)
First posted
Last updated

簡要摘要

LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑